“Leading Nanotechnologies” venture fund finances a project
“Leading Nanotechnologies” – a venture fund for low-budget projects financed the development of a new antiepileptic drug. The medicine will introduce a new mechanism of anticonvulsive action.
The issue becoming really topical, the drug will appear right on time: the population of the developed countries keeps aging while the number of registered incidents increases.
As of today, it’s the first time a fund created with the participation of RUSNANO financed a medical project.
The issue becoming really topical, the drug will appear right on time: the population of the developed countries keeps aging while the number of registered incidents increases.
As of today, it’s the first time a fund created with the participation of RUSNANO financed a medical project.
Похожее
“Leading Nanotechnologies” finances an antiepileptic drug development
RusnanoMedInvest and Domain Associates invest $40M in CoDa Therapeutics
Russian Venture Fund JetVenture finances three startups.
New nanotech-based cancer drug development nearing completion in Moscow